首页> 外文OA文献 >Lymphodepleting chemotherapy with donor lymphocyte infusion post-allogeneic HCT for hematological malignancies is associated with severe, but therapy-responsive aGvHD

【2h】

Lymphodepleting chemotherapy with donor lymphocyte infusion post-allogeneic HCT for hematological malignancies is associated with severe, but therapy-responsive aGvHD

机译：淋巴结的化疗与供体淋巴细胞输注后异导HCT用于血液恶性肿瘤的严重相关，但治疗反应性AGVHD

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
F He; E Warlick; J S Miller; M MacMillan; M R Verneris; Q Cao; D Weisdorf;
展开▼
作者单位

展开▼
年度 2016
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Lymphodepleting chemotherapy with donor lymphocyte infusion post-allogeneic HCT for hematological malignancies is associated with severe, but therapy-responsive aGvHD [J] . He F., Warlick E., Miller J. S., Bone marrow transplantation . 2016,第8期

机译：异体HCT后行供体淋巴细胞输注淋巴结放化疗用于血液系统恶性肿瘤与严重但对治疗有反应的aGvHD相关
2. Successful Remission Rates and Survival after Lymphodepleting Chemotherapy and Donor Lymphocyte Infusion for Relapsed Hematologic Malignancies Postallogeneic Hematopoietic Cell Transplantation [J] . WarlickE.D., DeForT., BlazarB.R., Biology of blood and marrow transplantation: journal of the American Society for Blood and Marrow Transplantation . 2012,第3期

机译：复发性血液系统恶性肿瘤邮政原代造血细胞移植的淋巴结放化疗和供体淋巴细胞输注后的成功缓解率和存活率。
3. Prophylactic donor lymphocyte infusions after moderately ablative chemotherapy and stem cell transplantation for hematological malignancies: high remission rate among poor prognosis patients at the expense of graft-versus-host disease. [J] . de-Lima M, Bonamino M, Vasconcelos Z, Bone marrow transplantation . 2001,第1期

机译：适度消融化疗和干细胞移植后血液系统恶性肿瘤的预防性供体淋巴细胞输注：预后差的患者中缓解率高，但要以移植物抗宿主病为代价。
4. Lymphodepleting chemotherapy with donor lymphocyte infusion post-allogeneic HCT for hematological malignancies is associated with severe but therapy-responsive aGVHD [O] . Fiona He, Erica Warlick, Jeffrey S. Miller, -1

机译：异体HCT的供血淋巴细胞灌注化疗与异体HCT对血液系统恶性肿瘤的发生相关但与严重的aGVHD疗效相关
5. Successful Remission Rates and Survival after Lymphodepleting Chemotherapy and Donor Lymphocyte Infusion for Relapsed Hematologic Malignancies Postallogeneic Hematopoietic Cell Transplantation [O] . Warlick Erica D., DeFor Todd, Blazar Bruce R., 2012

机译：复发性血液系统恶性肿瘤邮政原代造血细胞移植的淋巴结放化疗和供体淋巴细胞输注后的成功缓解率和存活率。

Lymphodepleting chemotherapy with donor lymphocyte infusion post-allogeneic HCT for hematological malignancies is associated with severe, but therapy-responsive aGvHD

著录项

引文网络

相似文献

相关主题

期刊订阅